Realyze Intelligence

A For the 13th consecutive year,?Innovation Works?and?Ernst & Young LLP (EY)?have released the region’s definitive report on the investment activity and trends shaping Pittsburgh’s entrepreneurial ecosystem. We were thrilled to hear from?Jake Loosararian, CEO of?Gecko Robotics, who shared a high-growth founder’s perspective on scaling a company nearing a $1B valuation—right here in Pittsburgh. Following that,?Darrell Smalley?and?Ven Raju?unpacked this year’s data, highlighting key takeaways from the report: - Pittsburgh saw its?fourth straight year?of more than?$1 billion in funding - Venture capital investment in Pittsburgh surged to $999M - AI and life sciences?led the charge as dominant investment sectors Dive deeper into the trends, sectors, and companies shaping our region’s innovation future in the full report here: https://buff.ly/JqCghWV. ? Later in the event,?Jeanne Iasella?hosted a dynamic panel featuring founders who led major deals in 2024. Each shared insights into the experience of building and growing in Pittsburgh: ??Alison Alvarez, BlastPoint ??Dan Godla, ThoroughCare ??Aaron Brauser, Realyze Intelligence ??Jamie Quinterno, Peca Labs A heartfelt thank you to?Ernst & Young?for your continued partnership and support of Pittsburgh’s innovation economy. #PittsburghTech #VentureCapital #Startups #Innovation #Entrepreneurship

We're excited to share a newly published article by our Co-Founder, Aaron Brauser, in Drug Discovery & Development: “Unlocking Bench-to-Bedside Discoveries Requires Better Data Sharing and Collaboration.” In it, Aaron explores how siloed clinical and research data continue to slow the pace of discovery—and what the life sciences community can do to fix it. At Realyze Intelligence, a Carta Healthcare company, we believe that unlocking real-world data trapped in unstructured clinical notes is a critical piece of the puzzle. ?? When data flows seamlessly between systems, researchers and clinicians can more quickly identify patterns, match patients to trials, and accelerate therapies to the people who need them most. ?? Read the full article to learn how smarter infrastructure, aligned incentives, and a culture of collaboration can transform translational research: ?? https://lnkd.in/gTziifM6 #RealWorldData #TranslationalResearch #ClinicalData #HealthTech #NoMoreZombieTrials #ClinicalTrialsForAll #AIinPrecisionOncology #AIPrecisionMedicine #LifeSciences #RealyzeIntelligence

At #HIMSS25 - Greg Miller, VP at Carta Healthcare, noticed a shift towards practical AI applications in a recent article in The American Journal of Healthcare Strategy -- “Generally speaking, AI was a hot topic at HIMSS, which is not a surprise. What felt slightly different though is that many vendors are leveraging AI for very practical and pragmatic use cases vs. AI being a new ‘shiny object.’ We saw a particular emphasis on how AI can support value-based care models and improve population health management through advanced analytics and predictive modeling.” #AIOncology #AIinPrecisionOncology #AIinHealthcare #NoMoreZombieTrials #ValueBasedCare

A recent Applied Clinical Trials Magazine article explores how technology is reshaping clinical trial design, and the impact is undeniable. The integration of AI-driven solutions yields significant downstream benefits, enhancing both efficiency and return on investment (ROI). ? ? AI-powered patient matching ? Improved trial diversity ? Optimized site selection ? Faster recruitment timelines ? Read more here: https://bit.ly/3FhCxI3 | #AI #MachineLearning #ClinicalTrials #ClinicalResearch #HealthcareInnovation #PatientRecruitment

Did you know that less than 15% of oncology clinical trial participants are minorities? In a joint research statement, ASCO & ACCC made a recommendation that *every* cancer patient be proactively screened for clinical trials to help combat the complex causes of inequity. ?Read more : https://lnkd.in/gWTuisGB Sound daunting or unfeasible? We can help. The Realyze Intelligence platform drives inclusivity in clinical trials by enabling screening at scale with existing resources. Further, we can capture hard-to-parse social determinants of health to drive future research and inclusive datasets. Join us in building a better oncology future.?Clinical Trials For All #DiversityInResearch #ClinicalInclusionMatters #CloseTheCareGap #PrecisionOncology #AIPrecisionOncology #ClinicalTrialsForAll #AIOncology?#RealyzeIntelligence

In his "Ctrl+Alt+Cure - Rebooting Cancer Care" substack - AI in Precision Oncology expert Douglas Flora, MD, FACCC, LSSBB perfectly describes the complexities of precision oncology at scale, “I see these challenges magnified across entire health systems. It's like watching thousands of dedicated healthcare professionals trying to navigate rush-hour traffic without real-time updates—each fighting through bottlenecks, searching for shortcuts, hoping they're making the best decisions with limited information.” Read more of his insights :: https://lnkd.in/gEnFupQa To put it simply : if you're in the proverbial traffic jam - Realyze can help. Our tools enhance & augment human, clinical expertise. We empower clinicians with data-driven insights for smarter, faster decision-making so they can navigate the complex & ever changing clinic environment. Whether it is personalized care for an individual patient or deep real-world data analysis to power the next precision medicine breakthrough - we can help. #AIinHealthcare #MedicalAI #FutureOfMedicine #HealthTech #RealyzeIntelligence #AIinPrecisionOncology

HUGE congrats to the 2025 CancerX Accelerator Cohort! As an alumni of this transformational program, we applaud the newest CancerX Moonshot members in tackling the biggest challenges in oncology. ???? Realyze Intelligence is proud to contribute solutions that accelerate clinical research and improve patient outcomes. #CancerMoonshot #OncologyAI #AIinHealthcare #DigitalHealthRevolution #AIinPrecisionOncology #NoMoreZombieTrials #RealyzeIntelligence

AI hype dominated the healthcare industry last year... In 2025 -?"experts say successful health systems can?get ahead of cost pressures by seeking out novel partnerships that allow them to do more while spending less".... no surprise, human-in-the-loop AI can help. #AdminEfficiencies #ClinicalWorkflows #UnlockingEfficiency #ClinicalTrialsforAll #NoMoreZombieTrials

Healthcare’s Biggest Data Problem — Solved Clinicians are drowning in data, yet critical insights remain buried in medical records. Realyze Intelligence & Carta Healthcare are changing that. Our AI-driven platform extracts and structures patient data, giving healthcare teams the information they need — when they need it. Let’s make data work for clinicians, not against them. Curious? Let's chat. https://lnkd.in/gn5DsJkT #DataDrivenHealthcare #HealthIT #AIinMedicine #DigitalTransformation #AIinPrecisionOncology #NoMoreZombieTrials #RealyzeIntelligence

Clinical Trials For All is partnering with patients, caregivers, patient advocates, health science companies, and advocacy groups to shine a light on the importance and benefits of clinical trial participation while enabling greater inclusion in research. ? Join us in spreading the word about clinical trials to our friends, family, colleagues, and future patients. ? Clinical Trials For All is a noncommercial initiative to increase global clinical trial participation by educating patients and caregivers about the opportunities and advantages of research as care. Learn more: https://bit.ly/4k0RRsn | #ClinicalTrialsForAll #ClinicalResearch #EducateEngageEmpower